Ketamine therapy for mental health a ‘wild West’ for doctors and patients

In late 2022, Sarah Gutilla’s treatment-resistant depression had grown so severe, she was actively contemplating suicide.

Year in Review: Follicular Lymphoma

Studies demonstrating high response rates and manageable safety profiles, along with FDA approvals, have supported bispecific antibodies as promising treatment options for follicular lymphoma. At

Read More »